Skip to main content

. 1992 Jan 25;304(6821):225–226. doi: 10.1136/bmj.304.6821.225

Detection of functional iron deficiency during erythropoietin treatment: a new approach.

I C Macdougall ¹, I Cavill ¹, B Hulme ¹, B Bain ¹, E McGregor ¹, P McKay ¹, E Sanders ¹, G A Coles ¹, J D Williams ¹

PMCID: PMC1881474 PMID: 1739797

225

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Cavill I. Disorders of iron metabolism. Diagnostic methods. Clin Haematol. 1982 Jun;11(2):259–273. [PubMed] [Google Scholar]
Eschbach J. W., Downing M. R., Egrie J. C., Browne J. K., Adamson J. W. USA multicenter clinical trial with recombinant human erythropoietin (Amgen). Results in hemodialysis patients. Contrib Nephrol. 1989;76:160–218. doi: 10.1159/000417892. [DOI] [PubMed] [Google Scholar]
Macdougall I. C., Hutton R. D., Cavill I., Coles G. A., Williams J. D. Poor response to treatment of renal anaemia with erythropoietin corrected by iron given intravenously. BMJ. 1989 Jul 15;299(6692):157–158. doi: 10.1136/bmj.299.6692.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
Moreb J., Popovtzer M. M., Friedlaender M. M., Konijn A. M., Hershko C. Evaluation of iron status in patients on chronic hemodialysis: relative usefulness of bone marrow hemosiderin, serum ferritin, transferrin saturation, mean corpuscular volume and red cell protoporphyrin. Nephron. 1983;35(3):196–200. doi: 10.1159/000183074. [DOI] [PubMed] [Google Scholar]
Van Wyck D. B., Stivelman J. C., Ruiz J., Kirlin L. F., Katz M. A., Ogden D. A. Iron status in patients receiving erythropoietin for dialysis-associated anemia. Kidney Int. 1989 Feb;35(2):712–716. doi: 10.1038/ki.1989.43. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES